CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
159 hedge funds and large institutions have $286M invested in Clovis Oncology, Inc. in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 50 increasing their positions, 44 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
26% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 35
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
159
Holding in Top 10
1
Calls
$19.8M
Puts
$26.1M
Top Buyers
| 1 | +$24.7M | |
| 2 | +$9.12M | |
| 3 | +$4.5M | |
| 4 |
Millennium Management
New York
|
+$3.88M |
| 5 |
AC
Armistice Capital
New York
|
+$2.06M |
Top Sellers
| 1 | -$6M | |
| 2 | -$5.83M | |
| 3 | -$5.41M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$4.31M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.56M |